本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

43.03
-1.5900-3.56%
成交量:45.07萬
成交額:1,941.52萬
市值:46.73億
市盈率:-23.26
高:45.02
開:44.69
低:42.61
收:44.62
52周最高:48.40
52周最低:13.85
股本:1.09億
流通股本:8,817.09萬
量比:0.65
換手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
淨資產收益率:-38.03%
總資產收益率:-25.03%
市淨率:10.43
市盈率(LYR):-26.40

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/16

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/07/13

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report